Patient centricity is far more than a buzzword in the pharmaceutical industry. Patient-centric options are also extending to clinical trial design, with sponsors considering how clinical trial materials can be formulated, packaged, and delivered in a manner that is both efficacious, stable, and convenient for patients, clinicians, and caretakers alike.
In order to ensure a smooth development and clinical process, companies must carefully plan their activities regarding to the innovator biopharmaceutical. If research, development, and clinical strategies are planned under the assumption that the innovator drug will function like a commodity, the final product may not be executable, and attempting to change a plan midstream is a recipe for delays, harming the company’s ability to break into the market early.
Accurate and timely delivery of clinical trial supplies helps to ensure that a study’s timeline stays on track. Sponsors often focus on up-front planning to ensure sites are prepared to reach clinical milestones, but they ignore the logistical challenges of reconciling and destroying clinical returns. This article breaks down how to effectively manage the clinical supply returns process and how to design a more holistic strategy.
Catalent in-house pharmaceutical sourcing specialists utilize a global network of leading manufacturers, wholesalers, and carefully selected QA-qualified healthcare professionals to provide cost-effective access to virtually any product. When you use Catalent for pharmaceutical sourcing you get a global distribution network that can deliver what you need, where you need it, and when you need it. Always in the right condition.